title: Non-Hodgkin's lymphoma of maxillary sinus: An unusual presentation.
abstract: Non-Hodgkin's Lymphoma (NHL) are a group of neoplasms that originate from the cells of the lymphoreticular system. Forty percent of Non-Hodgkin's lymphoma arises from extranodal sites. The nasal cavities and paranasal sinuses are rarely affected by primary NHL. Common primary extranodal sites of lymphomas include stomach, liver, soft tissue, dura, bone, intestine and bone marrow. Most patients present with rapidly enlarging masses, often with symptoms both locally and systemically (fever, recurrent night sweats, or weight loss). The vast majority of patients with localized disease are curable with combined modality therapy or combination chemotherapy alone. About 50% patients are cured with doxorubicin based combination chemotherapy and rituximab. An atypical case of extranodal Non-Hodgkin's lymphoma of maxillary sinus is discussed.
authors: Department of Oral and Maxillofacial Surgery, VYWS Dental College and Hospital, Maharashtra, India.
authors: Dwarkadas Gokuldas
authors: DG
authors: Adwani
authors: Rajender Singh
authors: RS
authors: Arora
authors: Anirudh
authors: A
authors: Bhattacharya
authors: Bhushan
authors: B
authors: Bhagat
keywords: Chemotherapy; diffuse large B-cell; immunohistochemistry; maxillary sinus; non-Hodgkin's lymphoma
references: Blood. 1994 Sep 1;84(5):1361-92
references: 8068936
references: J Oral Maxillofac Surg. 1995 Jul;53(7):827-9
references: 7595800
references: Tohoku J Exp Med. 1979 Aug;128(4):389-99
references: 483307
references: Top HIV Med. 2008 Oct-Nov;16(4):117-21
references: 18838745
references: J Oral Pathol. 1987 Jan;16(1):8-12
references: 3104566
references: Aust Dent J. 2010 Jun;55(2):203-6
references: 20604765
references: World J Surg Oncol. 2007 Aug 03;5:86
references: 17683562
references: J Oral Maxillofac Surg. 1997 Oct;55(10):1162-6
references: 9331243
references: N Engl J Med. 2008 Aug 7;359(6):613-26
references: 18687642